Comparative Analysis of Median Nerve Parameters for Carpal Tunnel Syndrome (CTS) Diagnosis: Ultrasound Versus Nerve Conduction Studies (NCS)
1 other identifier
interventional
50
1 country
1
Brief Summary
Comparative Analysis of Median Nerve Parameters for Carpal Tunnel Syndrome (CTS) Diagnosis: Ultrasound vs. Nerve Conduction Study (NCS) This clinical study aims to determine whether ultrasound can be as practical as NCS in diagnosing CTS. It will also evaluate the accuracy of different median nerve measurements in both tests. The main questions it aims to answer are: Can ultrasound accurately detect CTS compared to NCS? Which median nerve measurements (such as size, speed, or function) are most useful for diagnosis? Researchers will compare ultrasound and NCS results in patients with CTS symptoms to determine which test is more reliable and patient-friendly. Participants will:
- 1.Undergo both an ultrasound and a NCS for comparison.
- 2.Visit the clinic for testing and evaluation as part of the study.
- 3.Provide information about their symptoms and medical history related to CTS. This study aims to improve diagnosis accuracy and explore whether ultrasound could be a more comfortable and quicker alternative to NCS for detecting CTS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2025
CompletedFirst Posted
Study publicly available on registry
April 15, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedApril 15, 2025
April 1, 2025
2 months
March 15, 2025
April 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic Accuracy of Ultrasound Compared to Nerve Conduction Study for Carpal Tunnel Syndrome
Measuring the sensitivity, specificity, and overall accuracy of ultrasound in diagnosing CTS compared to NCS Parameters, including Median Nerve Latency, Amplitude, and Nerve Conduction Velocity
Baseline
Study Arms (2)
Ultrasound Diagnostic Arm
OTHERParticipants in this arm will undergo ultrasound imaging of the median nerve at the wrist. Measurements such as CSA and flattening ratio will be recorded. The goal is to evaluate ultrasound's effectiveness in diagnosing CTS compared to NCS.
Nerve Conduction Study (NCS) Group (Diagnostic Arm)
OTHERParticipants in this arm will undergo an NCS to assess median nerve function. Parameters such as nerve conduction velocity, latency, and amplitude will be recorded. NCS findings will serve as the gold standard for comparison with ultrasound results.
Interventions
This study involves two diagnostic interventions for evaluating CTS: Ultrasound Examination (Diagnostic Intervention) 1. A high-frequency ultrasound probe will be used to assess the median nerve at the wrist. 2. Parameters measured include cross-sectional area, flattening ratio, and echogenicity. The goal is to determine if ultrasound can accurately diagnose CTS compared to NCS. NCS (Diagnostic Intervention) 1. Surface electrodes will be placed on the skin to stimulate and record median nerve conduction. 2. Parameters such as latency, conduction velocity, and amplitude will be recorded. 3. NCS serves as the gold standard for diagnosing CTS and will be used for comparison with ultrasound results. Each participant will undergo both ultrasound and NCS, allowing researchers to compare their effectiveness in diagnosing CTS.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older.
- Patients with clinical symptoms of CTS, including numbness, tingling, pain, or weakness in the hand.
- Positive findings on clinical examination, such as Tinel's sign, Phalen's test, or Durkan's test.
- Willingness to undergo both ultrasound and NCS for diagnostic evaluation.
You may not qualify if:
- Previous surgery for CTS in the affected hand.
- History of peripheral neuropathy such as diabetic neuropathy
- Other neuromuscular disorders affecting the upper limb such as cervical radiculopathy.
- Pregnant women.
- Severe comorbid conditions that may interfere with study participation.
- Inability to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Combined Military Hospital
Kohat, KPK, 26000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Syed Tameem Ul Hassan, MBBS, FCPS
Combined Military Hospital Kohat
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
March 15, 2025
First Posted
April 15, 2025
Study Start
May 1, 2025
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
April 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- After the completion of study, data will be provided on demand and will be available for 6 months post completion.
- Access Criteria
- Researchers will be given access. Data will be shared via email.
Following IPD will be shared 1. De-identified demographic data that is age, gender, relevant medical history. 2. Ultrasound measurements of the median nerve such as CSA and flattening ratio. 3. NCS results such as latency, conduction velocity and amplitude. 4. Clinical assessment findings such as Tinel's sign, Phalen's test results.